Insmed
INSM
#542
Rank
โ‚น3.908 T
Marketcap
โ‚น18,327
Share price
-0.51%
Change (1 day)
187.29%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚น3.908 Trillion

As of December 2025 Insmed has a market cap of โ‚น3.908 Trillion. This makes Insmed the world's 542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น3.908 T265.86%
2024โ‚น1.068 T189.46%
2023โ‚น369.08 B64.78%
2022โ‚น223.99 B-6.67%
2021โ‚น240.00 B-3.23%
2020โ‚น248.01 B62.39%
2019โ‚น152.72 B115.34%
2018โ‚น70.92 B-53.49%
2017โ‚น152.48 B174.1%
2016โ‚น55.63 B-25.39%
2015โ‚น74.55 B52.68%
2014โ‚น48.83 B18.8%
2013โ‚น41.10 B256.38%
2012โ‚น11.53 B187.87%
2011โ‚น4.00 B-9.45%
2010โ‚น4.42 B-4.89%
2009โ‚น4.65 B69.26%
2008โ‚น2.74 B-30.36%
2007โ‚น3.94 B-0.06%
2006โ‚น3.94 B-33.03%
2005โ‚น5.89 B37.94%
2004โ‚น4.27 B-17.65%
2003โ‚น5.19 B626.6%
2002โ‚น0.71 B-88.23%
2001โ‚น6.07 B14.31%
2000โ‚น5.31 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Insmed was reported to be:

โ‚น3.908 Trillion
by Nasdaq info icon info icon
โ‚น3.908 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น209.54 B-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.781 T 482.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น13.512 T 245.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น108.68 B-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น67.70 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น10.491 T 168.41%๐Ÿ‡บ๐Ÿ‡ธ USA